Centaurus Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $724K | Buy |
5,985
+11
| +0.2% | +$1.33K | 0.04% | 365 |
|
|
2025
Q1 | $666K | Sell |
5,974
-291
| -5% | -$32.4K | 0.04% | 378 |
|
|
2024
Q4 | $610K | Buy |
6,265
+537
| +9% | +$52.3K | 0.04% | 382 |
|
|
2024
Q3 | $659K | Buy |
5,728
+98
| +2% | +$11.3K | 0.04% | 353 |
|
|
2024
Q2 | $599K | Buy |
5,630
+995
| +21% | +$106K | 0.04% | 347 |
|
|
2024
Q1 | $448K | Buy |
4,635
+884
| +24% | +$85.4K | 0.03% | 413 |
|
|
2023
Q4 | $379K | Sell |
3,751
-75
| -2% | -$7.58K | 0.03% | 420 |
|
|
2023
Q3 | $390K | Buy |
3,826
+319
| +9% | +$32.5K | 0.03% | 405 |
|
|
2023
Q2 | $354K | Sell |
3,507
-974
| -22% | -$98.3K | 0.03% | 428 |
|
|
2023
Q1 | $412K | Buy |
4,481
+1,355
| +43% | +$125K | 0.03% | 458 |
|
|
2022
Q4 | $284K | Sell |
3,126
-878
| -22% | -$79.8K | 0.03% | 504 |
|
|
2022
Q3 | $304K | Buy |
4,004
+1,349
| +51% | +$102K | 0.03% | 480 |
|
|
2022
Q2 | $224K | Buy |
+2,655
| New | +$224K | 0.02% | 578 |
|
|
2020
Q3 | – | Sell |
-9,769
| Closed | -$853K | – | 679 |
|
|
2020
Q2 | $853K | Sell |
9,769
-2
| -0% | -$175 | 0.13% | 190 |
|
|
2020
Q1 | $806K | Sell |
9,771
-2,823
| -22% | -$233K | 0.16% | 157 |
|
|
2019
Q4 | $1.19M | Buy |
12,594
+5,496
| +77% | +$521K | 0.17% | 138 |
|
|
2019
Q3 | $617K | Buy |
7,098
+5,514
| +348% | +$479K | 0.1% | 242 |
|
|
2019
Q2 | $145K | Buy |
1,584
+1,432
| +942% | +$131K | 0.02% | 497 |
|
|
2019
Q1 | $1.42K | Buy |
152
+2
| +1% | +$19 | 0.01% | 508 |
|
|
2018
Q4 | $2 | Buy |
150
+149
| +14,900% | +$2 | 0.01% | 417 |
|
|
2018
Q3 | $108 | Sell |
1
-3,497
| -100% | -$378K | 0.02% | 507 |
|
|
2018
Q2 | $237K | Buy |
+3,498
| New | +$237K | 0.03% | 481 |
|